The innovation and development of the pharmaceutical equipment industry has become a trend Head enterprises have opened a large-scale expansion of talents

【Pharmaceutical Network Market Analysis】At present, under the background of the acceleration of the transformation and upgrading of the pharmaceutical industry and the series of policies to encourage the manufacturing industry to develop in the high-end direction, the opportunities and challenges of the pharmaceutical equipment industry coexist, and innovation and development have become a trend
.

The industry believes that the innovation and development of the industry is inseparable from investment and talents, and from the perspective of the actions of the head enterprise, these two aspects have been accelerated
.

Pharmaceutical equipment industry (image source: pharmaceutical network) Pharmaceutical equipment industry innovation and development into a trend Pharmaceutical equipment is the "mother machine" of pharmaceutical production, and its industrial development level is closely
related to the pharmaceutical level.

In recent years, with the rapid development of the pharmaceutical industry and the acceleration of innovation and upgrading, as well as the continuous breakthrough of emerging biotechnology in China, the promotion of emerging industries such as biomedicine and health industry, the market demand for high-end pharmaceutical equipment has been expanding
.

At present, China has successively issued a series of encouragement policies such as the Outline of the National Medium- and Long-term Science and Technology Development Plan, the Catalogue for the Guidance of Industrial Structure Adjustment, and several opinions on accelerating the revitalization of the equipment manufacturing industry to encourage and support the innovative development
of the manufacturing industry.

Among them, in January this year, the Ministry of Industry and Information Technology and other nine departments jointly issued the "14th Five-Year" Pharmaceutical Industry Development Plan" clearly proposed that it is necessary to deeply implement intelligent manufacturing, green manufacturing and quality improvement actions, improve the quality management level and product quality of the whole life cycle of drugs and medical devices, and promote the high-end, intelligent and green development of
the pharmaceutical industry.

Many institutions believe that in the context of innovation and upgrading of the pharmaceutical industry, the upstream pharmaceutical equipment industry also needs to be innovated, and it is developing in the high-end direction of intelligence, informatization, integration, and greening, so as to better meet the needs of high-quality and sustainable development of
the modern pharmaceutical industry.

Head enterprises open large-scale talent expansion So, how should the pharmaceutical equipment industry innovate and develop? The industry believes that one depends on investment, the other depends on talents
.

Investment is the material basis for enterprise innovation, and only through corresponding capital investment can we promote innovation and harvest results
.

For the high-threshold pharmaceutical equipment industry with complex disciplines, the higher the technology content, especially the key technology of "card neck", the greater
the investment required.

In recent years, domestic pharmaceutical equipment enterprises have paid more and more attention to R & D investment
.

Taking Chutian Technology as an example, in recent years, Chutian Technology's annual expenditure on R&D investment accounts for about
10% of revenue.

According to the 2022 interim report, Chutian Technology invested 232 million yuan in research and development during the reporting period, an increase of 17.
32%
year-on-year.

Another example is Dongfulong, the company's R & D investment has also increased year by year, and the company's R & D investment ratio will rise to 6.
79%
in 2021.

In the first half of 2022, the company's R&D investment was 151 million yuan, an increase of 53.
00%
year-on-year.

Talent is the source of enterprise innovation, but also the core element of enterprise innovation, high-tech product development and production largely depends on professional talents
.

Pharmaceutical equipment enterprises should be talent-oriented, build a team of high-quality scientific and technological talents, and create hard power
.

At present, the head enterprises are actively taking action
to expand talent recruitment.

Chutian Technology's 2022 semi-annual report shows that the number of technical research and development personnel in the first half of the year increased by more than 650 compared with the same period, and the introduction of technical backbone talents is the focus and shows obvious results, and the number of technical research and development personnel of the group during the reporting period is nearly 2,000
.

In addition, Dongfulong also mentioned in the report that the company increased R & D personnel in the first half of the
year.

From 2020 to 2021, the number of R&D personnel in Dongfulong increased from 396 (14.
88%) to 677 (18.
44%)
.

It is worth mentioning that according to the "2022 Enterprise Fresh Graduate Policy Special Survey", the proportion of fresh graduate recruitment in enterprises this year has decreased compared with last year, and nearly 30% of enterprises have not recruited fresh graduates
.

Chu Tian is a "retrograde", recruiting more than 530 fresh graduates
from domestic and foreign universities.

According to reports, this year is also the year that Chutian Technology has recruited the most fresh college graduates in the past 22 years, which shows that the group attaches great importance
to "fresh blood".

Disclaimer: In no event shall the information or opinions expressed herein constitute investment advice
to any person.